Logo Image
News
All NewsAAP NewsPNP Corner
Media
Clinical Forum InsightsCure ConnectionsExpert InterviewsInsightsMedcastPeer ExchangePeers & PerspectivesPodcastsShortsSpecial ReportsSponsored VideosWebinars
Puzzler
Publications
Contemporary Pediatrics JournalSupplements And Featured Publications
More
CME/CE
Resources
HandoutsJob BoardProduct ProfileSponsored
Conferences
Conference CoverageConference Listing
Partnerships
Editorial
Editorial Advisory BoardWriter’s GuidelinesReference GuidelinesMeet the Editors

Subscribe

  • News
  • Media
  • Puzzler
  • Publications
  • CME/CE
  • Resources
  • Conferences
  • Partnerships
  • Subscribe
  • Editorial
  • Allergy, Immunology, and ENT
    • Food Allergies
    • Animal Allergies
  • Cardiology
    • Cardiovascular Diseases
  • Dermatology
    • Hidradenitis Suppurativa
    • Atopic Dermatitis
    • Acne
  • Emergency Medicine
  • Endocrinology
    • Type 1 Diabetes
    • Type 2 Diabetes
  • Gastroenterology
    • Formula
    • Obesity
  • Genetic Disorders
  • Genetic Testing
  • Infectious Diseases
    • COVID-19
    • RSV
    • Influenza
    • Antibiotic Resistance
    • Vaccination and Immunization
    • Bacterial Conjunctivitis
    • Pneumonia
    • Sexually Transmitted Diseases
  • Mental, Behavioral and Development Health
    • Anxiety
    • Autism
    • Developmental/Behavioral Disorders
    • Depression
    • Psychiatry
    • ADHD
    • Addiction
    • Antisocial Personality Disorder
  • Neurology
    • Concussion
    • Epilepsy
    • Headache
  • Nutrition
  • OB/GYN
    • Neonatal/Perinatology
  • Pain
  • Pharmacology
    • Drug Pipeline News
  • Practice Improvement
    • Telemedicine
  • Rare Disease
  • Respiratory
    • Asthma
    • Cystic Fibrosis
  • Rheumatology
Advertisement

Sarah McLeod, PhD

Advertisement
Sarah McLeod, PhD | Image Credit: Sarah McLeod LinkedIn

Sarah McLeod, PhD, senior director of Clinical Microbiology at Innoviva Specialty Therapeutics.

Articles by Sarah McLeod, PhD

Sarah McLeod, PhD

Sarah McLeod, PhD, breaks down high cure rates with zoliflodacin for uncomplicated gonorrhea

ByJoshua Fitch, Senior Editor ,Sarah McLeod, PhD
October 27th 2025

Zoliflodacin study investigator Sarah McLeod, PhD, highlights data presented at IDWeek 2025 in this Q&A with Contemporary Pediatrics.

Advertisement

Latest Updated Articles

  • Sarah McLeod, PhD
    Sarah McLeod, PhD, breaks down high cure rates with zoliflodacin for uncomplicated gonorrhea

    October 27th 2025



Advertisement
Advertisement

Trending on Contemporary Pediatrics

1

Julie Khlevner, MD, discusses the impact of FDA-approved LINZESS for functional constipation

2

FDA approves ensitrelvir for post-exposure prevention of COVID-19 in adolescents and adults

3

Recognizing the skin findings that distinguish pediatric hidradenitis suppurativa

4

Colleen Cotton, MD, on the importance of early recognition in hidradenitis suppurativa

5

FDA accepts mavacamten (Camzyos) application for adolescent obstructive hypertrophic cardiomyopathy

  • About Us
  • Advertise
  • Contact Us
  • Editorial
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us